Aziyo Biologics Announces Pricing of Initial Public Offering

Aziyo Biologics OsteoGro Bone Matrix

Aziyo Biologics priced its initial public offering of 2,941,176 shares of common stock at a public offering price of $17/share.

The company's FiberCel, ViBone and OsteGro V viable bone matrices address orthopedic and spine applications. FiberCel is sold exclusively through Medtronic, while ViBone is available exclusively through an...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us